PRKAB1 and neoplasm: Moreover, metformin can induce AMPK-dependent metabolic regulation of T cells in TIME, thereby enhancing their activity and increasing the quantity and force of TM, thereby enhancing genetic immunity and tolerance, and thereby increasing the response and efficiency of tumor immunotherapy [118].